Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.
Published October 29, 2025 · Recall initiated: September 12, 2025
Summary
FDA records drug Class III recall D-0032-2026, published October 29, 2025 and initiated September 12, 2025. Recalling firm: JB Chemicals and Pharmaceuticals Ltd; Status: Ongoing; Reported quantity: 9936 bottles; Lot: Lot # PY925014A; Exp. 1/31/2028. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Tablet/Capsules Imprinted with Wrong ID
What to do
Voluntary: Firm initiated · Letter
Get an email if CETIRIZINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CETIRIZINE HYDROCHLORIDE
- Manufacturer
- JB Chemicals and Pharmaceuticals Ltd
- Distributor
- U.S. Nationwide
- Lot
- Lot # PY925014A; Exp. 1/31/2028
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDACetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (AJuly 29, 2026
- FDACetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs,October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by:October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by:October 29, 2025
- FDAOlopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLAOctober 29, 2025
- FDAChildren's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by SandozOctober 24, 2012
Questions about this recall
Was Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10. recalled?
Yes. FDA published recall D-0032-2026 on October 29, 2025. Reported hazard: Tablet/Capsules Imprinted with Wrong ID
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CETIRIZINE HYDROCHLORIDE.